PLA2G7 and coronary atherosclerosis: It is noteworthy that a similar level of plaque Lp-PLA2 activity inhibition was achieved with darapladib in a porcine model of coronary atherosclerosis, because in this model, Lp-PLA2 inhibition was accompanied by a significant reduction in complex plaque development [13].